CNMD · CONMED Corp
$43.02
-1.23 (-2.78%)
At close · Jul 29
Earnings today
Market Cap
$1.36B
Shares
30.83M
CONMED Corp Earnings Call Transcripts
Every quarterly earnings call for CONMED Corp (CNMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲10.6%
$275.09M
$46.15M
'22 Q3
22-10-26
▼8.4%
$250.87M
$26.57M
'22 Q4
23-02-02
▲21.9%
$295.47M
$1.82M
'23 Q1
23-04-26
▲14.6%
$317.65M
$13.73M
'23 Q2
23-07-26
▲10.7%
$304.58M
$15.84M
'23 Q3
23-10-25
▲30.4%
$327.05M
$33.11M
'23 Q4
24-01-31
▲5.7%
$312.27M
$19.71M
'24 Q1
24-04-24
▲4.5%
$332.10M
$29.98M
'24 Q2
24-07-31
▲4%
$316.70M
$48.98M
'24 Q3
24-10-04
▲5.8%
$345.94M
$33.73M
'24 Q4
25-02-05
▲2.9%
$321.26M
$6.04M
'25 Q1
25-04-30
▲3.1%
$342.35M
$21.42M
'25 Q2
25-07-30
▲6.7%
$337.93M
$2.86M
'25 Q3
25-11-05
LATEST
▲7.9%
$373.20M
$16.78M
'25 Q4
26-01-28
Earnings call
FY26 · Q2
2026-07-29
Q2 FY26 CONMED Earnings Conference Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-29
CONMED Corp Q1 FY2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
CONMED Corp Q4 FY2025 Earnings Call
Confident tone
Q4 and full-year 2025 results
International vs. US geographic mix
AirSeal insufflation platform
Revenue
$373.20M*
▲ 7.9% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
CONMED Corp Q3 FY2025 Earnings Call
Positive tone
General surgery platforms (AirSeal, Buffalo Filter)
Orthopedics growth (BioBrace, Foot & Ankle)
Tariff and margin headwinds
Revenue
$337.93M
▲ 6.7% YoY Diluted EPS
$0.09
▼ 94.3% YoY Gross margin
49.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
CONMED Corp Q2 FY2025 Earnings Call
Positive tone
AirSeal growth platform
Supply chain recovery in orthopedics/sports medicine
Tariff impact
Revenue
$342.35M
▲ 3.1% YoY Diluted EPS
$0.69
▼ 28.1% YoY Gross margin
55.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
CONMED Corp Q1 FY2025 Earnings Call
Positive tone
Tariff exposure and mitigation
Full-year guidance and growth algorithm
General Surgery segment and AirSeal adoption
Revenue
$321.26M
▲ 2.9% YoY Diluted EPS
$0.19
▼ 69.8% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-05
CONMED Corp Q4 FY2024 Earnings Call
Positive tone
Orthopedic supply challenges
Margin and profitability improvement
AirSeal growth
Revenue
$345.94M*
▲ 5.8% YoY Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-04
CONMED Corp Q3 FY2024 Earnings Call
Balanced tone
CEO succession and leadership transition
2025 guidance and outlook
Earnings, cash flow, and leverage performance
Revenue
$316.70M
▲ 4% YoY Diluted EPS
$1.57
▲ 214% YoY Gross margin
56.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
CONMED Corp Q2 FY2024 Earnings Call
Revenue
$332.10M
▲ 4.5% YoY Diluted EPS
$0.96
▲ 123.3% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
CONMED Corp Q1 FY2024 Earnings Call
Positive tone
New product launches
Full year guidance
Revenue growth drivers
Revenue
$312.27M
▲ 5.7% YoY Diluted EPS
$0.63
▲ 950% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
CONMED Corp Q4 FY2023 Earnings Call
Confident tone
AirSeal Competitive Position vs. Intuitive
Orthopedics and BioBrace
Capital and Single-Use Mix
Revenue
$327.05M*
▲ 30.4% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
CONMED Corp Q3 FY2023 Earnings Call
Revenue
$304.58M
▲ 10.7% YoY Diluted EPS
$0.50
▼ 66.2% YoY Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
CONMED Corp Q2 FY2023 Earnings Call
Revenue
$317.65M
▲ 14.6% YoY Diluted EPS
$0.43
Gross margin
53.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
CONMED Corp Q1 FY2023 Earnings Call
Revenue
$295.47M
▲ 21.9% YoY Diluted EPS
$0.06
▼ 87.2% YoY Gross margin
52.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-02
CONMED Corp Q4 FY2022 Earnings Call
Revenue
$250.87M*
▼ 8.4% YoY Gross margin
52.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-26
CONMED Corp Q3 FY2022 Earnings Call
Revenue
$275.09M
▲ 10.6% YoY Diluted EPS
$1.48
▲ 214.9% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
CONMED Corp Q2 FY2022 Earnings Call
Revenue
$277.19M
▲ 8.6% YoY Diluted EPS
$-5.65
▼ 1478% YoY Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
CONMED Corp Q1 FY2022 Earnings Call
Revenue
$242.33M
▲ 4.1% YoY Diluted EPS
$0.47
▲ 51.6% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
CONMED Corp Q4 FY2021 Earnings Call
Revenue
$273.97M*
▲ 8.4% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-27
CONMED Corp Q3 FY2021 Earnings Call
Revenue
$248.83M
▲ 4.6% YoY Diluted EPS
$0.47
▲ 104.3% YoY Gross margin
57.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
CONMED Corp Q2 FY2021 Earnings Call
Revenue
$255.16M
▲ 61.7% YoY Diluted EPS
$0.41
Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
CONMED Corp Q1 FY2021 Earnings Call
Revenue
$232.68M
▲ 8.7% YoY Diluted EPS
$0.31
▲ 55% YoY Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
CONMED Corp Q4 FY2020 Earnings Call
Revenue
$252.83M
▼ 4.5% YoY Diluted EPS
$0.81
▲ 65.3% YoY Gross margin
53.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-28
CONMED Corp Q3 FY2020 Earnings Call
Revenue
$237.84M
▲ 1.8% YoY Diluted EPS
$0.23
▲ 0% YoY Gross margin
56.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
CONMED Corp Q2 FY2020 Earnings Call
Revenue
$157.78M
▼ 33.8% YoY Diluted EPS
$-0.96
▼ 605.3% YoY Gross margin
45.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
CONMED Corp Q1 FY2020 Earnings Call
Revenue
$214.01M
▼ 2% YoY Diluted EPS
$0.20
▲ 400% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-29
CONMED Corp Q4 FY2019 Earnings Call
Revenue
$264.87M
▲ 9.2% YoY Diluted EPS
$0.49
▼ 9.3% YoY Gross margin
53.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
816956
CUSIP
207410101
13F (30d)
48 filings
48 filers
Visit website
Investor relations